Internal Medicine, Hematology & Oncology · Guayama, PR
NPI
1861474223
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
La Fuente Town Center, Marginal 706 Ste 11139
Guayama, PR, 00784
Phone (787) 866-1500
Groups this clinician bills Medicare through
Medicare paid, 2022
$86K
5,251 services
Medicare patients, 2022
49
Average age 69
Drug cost, 2024
$8.5M
1,728 prescriptions
Company payments, 2025
$313
From 5 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Samuel A Gonzalez was code 99214 (office e&m - established), 70 times for 30 patients. In total Samuel A Gonzalez billed 5,251 services in 28 codes, and Medicare paid $86K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 70 | 30 | $95.82 | $6,708 |
| 99213 Office E&M - Established | Office | 22 | 18 | $41.91 | $922 |
| 99211 Office E&M - Established | Office | 21 | 13 | $11.10 | $233 |
| 99204 Office E&M - New | Office | 13 | 13 | $124.33 | $1,616 |
Medicare prescription drug claims, 2024
In 2024, the drug Samuel A Gonzalez prescribed most often to Medicare patients was Anastrozole, with 532 prescriptions and refills. In total Samuel A Gonzalez wrote 1,728 Medicare prescriptions that cost $8.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 532 | 661 | 95 | $7,962 |
| Revlimid Lenalidomide | 135 | 135 | 13 | $3.0M |
| Dexamethasone Generic | 111 | 111 | 27 | $1,917 |
| Hydroxyurea Generic | 79 | 79 | 13 | $2,290 |
| Exemestane Generic | 69 | 79 | 11 | $6,003 |
| Ibrance Palbociclib | 64 | 64 | Under 11 | $1.0M |
| Prednisone Generic | 61 | 63 | 16 | $411 |
| Sprycel Dasatinib | 54 | 54 | Under 11 | $677K |
| Abiraterone Acetate Generic | 50 | 50 | Under 11 | $17K |
| Erleada Apalutamide | 43 | 43 | Under 11 | $644K |
| Keytruda Pembrolizumab | 43 | 45 | Under 11 | $586K |
| Eliquis Apixaban | 37 | 37 | Under 11 | $22K |
| Synthroid Levothyroxine Sodium | 29 | 35 | Under 11 | $1,715 |
| Tamoxifen Citrate Generic | 23 | 33 | Under 11 | $1,333 |
| Ondansetron Hcl Generic | 22 | 22 | 20 | $1,625 |
Brand drugs: 600 claims; generic drugs: 1,128 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samuel A Gonzalez $313 ($313 in general payments such as food, travel and fees) from 5 companies. The largest payer was Janssen Biotech, Inc. with $186.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.